PulseAugur
EN
LIVE 09:09:32

New EchoRisk dataset targets early detection of therapy-induced cardiotoxicity

By PulseAugur Editorial · [2 sources] ·

Researchers have introduced EchoRisk, a new dataset and benchmark designed for early detection of cardiotoxicity in cancer patients undergoing therapy. This dataset, derived from the CARDIOCARE study, includes longitudinal echocardiography videos from over 400 patients across five European sites. It supports three tasks: estimating ejection fraction, classifying left ventricular dysfunction, and predicting cardiotoxicity from baseline imaging, with initial baselines showing strong performance in functional assessment but highlighting early cardiotoxicity prediction as an open challenge. AI

IMPACT This dataset could accelerate AI-driven advancements in early detection and prevention of cardiotoxicity in cancer patients.

RANK_REASON The item is a research paper introducing a new dataset and benchmark for a specific medical application. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.AI →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

New EchoRisk dataset targets early detection of therapy-induced cardiotoxicity

COVERAGE [2]

  1. arXiv cs.AI TIER_1 English(EN) · Grigorios Kalliatakis, Georgia Karanasiou, Georgios Manikis, Manolis Tsiknakis, Dimitrios Fotiadis, Dorothea Tsekoura, Kalliopi Keramida, Vasileios Bouratzis, Lampros Lakkas, Katerina Naka, Andri Papakonstantinou, Anastasia Constantinidou, Kostas Marias ·

    EchoRisk: A Multicentre Echocardiography Dataset and Benchmark for Cardio-Oncology

    arXiv:2607.01039v1 Announce Type: cross Abstract: Therapy-induced cardiotoxicity is the leading non-oncological cause of treatment interruption in breast cancer patients, yet early, automated risk stratification from routine cardiac imaging remains an unsolved problem. We present…

  2. arXiv cs.AI TIER_1 English(EN) · Kostas Marias ·

    EchoRisk: A Multicentre Echocardiography Dataset and Benchmark for Cardio-Oncology

    Therapy-induced cardiotoxicity is the leading non-oncological cause of treatment interruption in breast cancer patients, yet early, automated risk stratification from routine cardiac imaging remains an unsolved problem. We present EchoRisk, the first curated, multicentre, longitu…

RELATED ENTITIES

RELATED TOPICS